Clinical value of tapentadol extended-release in painful diabetic peripheral neuropathy.

about

Evaluating the Phase II drugs currently under investigation for diabetic neuropathy.Progress in the treatment of small fiber peripheral neuropathy.Pain in the Frail or Elderly Patient: Does Tapentadol Have a Role?Small fiber neuropathy: Getting bigger!

P2860

Q38244605-473D84EA-EE17-459D-857D-899765E69110 Q38349089-32B1BDCB-051B-4B7A-B456-4184BBBE3437 Q38508009-32D494E1-9FF5-43B6-A5C8-2BD81B805F2D Q38731621-1B7B2E8B-1BAE-4A52-9CB6-FC0BACFF525D

P2860

Clinical value of tapentadol extended-release in painful diabetic peripheral neuropathy.

Item

http://www.wikidata.org/entity/Q38187698

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Clinical value of tapentadol extended-release in painful diabetic peripheral neuropathy.

@en

type

Item

label

Clinical value of tapentadol extended-release in painful diabetic peripheral neuropathy.

@en

prefLabel

Clinical value of tapentadol extended-release in painful diabetic peripheral neuropathy.

@en

P1476

Clinical value of tapentadol extended-release in painful diabetic peripheral neuropathy

@en

P2093

Bansri Desai

http://www.w3.org/2001/XMLSchema#string

Edward Knapp

http://www.w3.org/2001/XMLSchema#string

Ellen Huang

http://www.w3.org/2001/XMLSchema#string

Erin Freeman

http://www.w3.org/2001/XMLSchema#string

Fadia T Shaya

http://www.w3.org/2001/XMLSchema#string

Mary L McPherson

http://www.w3.org/2001/XMLSchema#string

P2860

A comparison between enriched and nonenriched enrollment randomized withdrawal trials of opioids for chronic noncancer pain

Advances in perioperative pain management: use of medications with dual analgesic mechanisms, tramadol & tapentadol

Guidelines in the management of diabetic nerve pain: clinical utility of pregabalin.

Diabetic neuropathy: scope of the syndrome.

Evidence-based guideline: Treatment of painful diabetic neuropathy: report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitati

EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision.

Review of the effect of opioid-related side effects on the undertreatment of moderate to severe chronic non-cancer pain: tapentadol, a step toward a solution?

Diabetic neuropathy: clinical manifestations and current treatments.

Safety and efficacy of tapentadol ER in patients with painful diabetic peripheral neuropathy: results of a randomized-withdrawal, placebo-controlled trial.

Tapentadol in pain management: a μ-opioid receptor agonist and noradrenaline reuptake inhibitor.

P304

203-209

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/17512433.2014.889562

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Ian M Breunig

Anna Hung

P577

2014-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24524594

http://www.w3.org/2001/XMLSchema#string

Clinical value of tapentadol extended-release in painful diabetic peripheral neuropathy.

about

P2860

P2860

Clinical value of tapentadol extended-release in painful diabetic peripheral neuropathy.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698